Search Results for "Recall Promus Heart Stent"

14:50 EDT 24th October 2014 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Transplantation

Heart Failure HF

Matching News

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREM...

Boston Scientific gets Japanese OK for Promus Premier stent

Japanese regulators have given Boston Scientific the go-ahead to market its Promus Premier system, a coronary drug-eluting st -More- 

Boston Scientific reports strong performance data for Synergy stent system

Boston Scientific has reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the Synergy everolimus-eluting bioabsorbable polymer platinum c...

Boston Scientific Launches Everolimus-Eluting Coronary Stent In Japan

Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation has launched the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan....

Boston Scientific Launches Stent Trial In Underserved Populations

PLATINUM Diversity trial will examine Promus Premier stent in women and people of color, populations that have been underrepresented in previous trials. The trial coincides with the company’s Close ...

Strong Performance Data Reported for SYNERGY Stent System Trial

EVOLVE Study Data Presented Today at EuroPCR 2014 Also Demonstrate Excellent Safety Profile Boston Scientific Corporation reported positive three-year follow-up data for the EVOLVE clinical trial, com...

Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time One-year results show Absorb provides co...

Abbott dissolving stent has lower angina rate vs metal stent: study

(Reuters) - Abbott's Absorb dissolving heart stent proved as safe and effective one year after being placed in a diseased artery as the company's market-leading Xience drug coated metal stent with a s...

Matching PubMed Articles

Snare removal of a deformed coronary stent via radial artery during percutaneous intervention for acute myocardial infarction.

A 49-year-old man underwent emergent coronary angiography for acute inferior myocardial infarction (MI). After balloon angioplasty of culprit right coronary artery (RCA) occlusion, a Promus Element st...

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.

To investigate the putative modifying effect of dual antiplatelet therapy (DAPT) use on the incidence of stent thrombosis at 3 years in patients randomized to Endeavor zotarolimus-eluting stent (E-ZES...

Effect of Valve Design on the Stent Internal Diameter of a Bioprosthetic Valve: A Concept of True Internal Diameter and Its Implications for the Valve-in-Valve Procedure.

The goal of this study was to provide a measurement of the true internal diameter (ID) of various surgical heart valves (SHV) to facilitate the valve-in-valve (VIV) procedure. During a VIV procedure, ...

Spectral Analysis Related to Bare-Metal and Drug-Eluting Coronary Stent Implantation.

Background: The autonomic nervous system plays a central role in cardiovascular regulation; sympathetic activation occurs during myocardial ischemia. Objective: To assess the spectral analysis of hear...

Occurrence of longitudinal stent compression before stent deployment: Two case studies.

Several recent reports have described the occurrence of longitudinal stent deformation (LSD, defined as the distortion or shortening of a stent along the longitudinal axis), following its successful d...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement